News & Events CTI Clinical Trial and Consulting Services Announces Shelly Brewer, RN, BSN, MBA has joined as Director, Global Safety & Pharmacovigilance

CTI Clinical Trial and Consulting Services Announces Shelly Brewer, RN, BSN, MBA has joined as Director, Global Safety & Pharmacovigilance

January 24, 2014

FOR IMMEDIATE RELEASE [Cincinnati, OH ~ January 24, 2014] CTI Clinical Trial and Consulting Services (CTI) announces Shelly Brewer, RN, BSN, MBA has joined as Director, Global Safety & Pharmacovigilance.

Shelly comes to CTI from INC Research, formally known as Kendle International, where she served as Associate Director, Global Safety & Pharmacovigilance for the past three years. Shelly spent over 15 years at INC Research/Kendle International working in the safety department in roles of increasing responsibility. She has experience with all aspects of safety and pharmacovigilance, including case management, safety systems, client relations, and personnel management.

Shelly began her career as a Clinical Nurse with a specialty in solid organ transplantation at Cincinnati Children’s Hospital. She earned her Master of Business Administration from Thomas More College and Bachelor of Science in Nursing from the University of Cincinnati College of Nursing and Health.

“We are very excited for Shelly to join our team,” said Melanie Bruno, Vice President, Clinical Trial Operations at CTI. “Her expertise in global safety and pharmacovigilance will be a great asset to CTI as we continue to expand coverage across the world.”

 

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is an innovative, international drug and device development organization that delivers a full spectrum of clinical trial and consulting services from bench to commercialization with a focus on immunology and a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology and startup firms with clinical and disease area expertise from a unique mix of academic, medical and industry specialists; rich intellectual capital in transplantation, immunology, infectious diseases, hematology, cardiology, nephrology, hepatology, regenerative medicine and rare diseases; flexible study designs that accelerate development programs and deliver high approval ratings that are among the best in the industry; and exceptional global project management and gold standard safety and data management systems that strengthen their program’s success potential. Established in 1999 and headquartered in Cincinnati, OH; CTI has offices in North America, Europe and South America.

Subscribe to our mailing list

* indicates required